Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases
Publication date
2021-02-24
Authors
Furer, Victoria
Rondaan, Christien
Agmon-Levin, Nancy
Van Assen, Sander
Bijl, Marc
Kapetanovic, Meliha Crnkic
De Thurah, Annette
Mueller-Ladner, Ulf
Paran, Daphna
Schreiber, Karen
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.
Keywords
autoimmune diseases, COVID-19, vaccination, Immunology and Allergy, Rheumatology, Immunology
Citation
Furer, V, Rondaan, C, Agmon-Levin, N, Van Assen, S, Bijl, M, Kapetanovic, M C, De Thurah, A, Mueller-Ladner, U, Paran, D, Schreiber, K, Warnatz, K, Wulffraat, N M & Elkayam, O 2021, 'Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases', RMD Open, vol. 7, no. 1, e001594. https://doi.org/10.1136/rmdopen-2021-001594